Is targeting of CD47-SIRPα enough for treating hematopoietic malignancy?
Blood
.
2012 May 3;119(18):4333-4; author reply 4334-5.
doi: 10.1182/blood-2011-11-391367.
Authors
Xi Wen Zhao
,
Taco W Kuijpers
,
Timo K van den Berg
PMID:
22555661
DOI:
10.1182/blood-2011-11-391367
No abstract available
Publication types
Letter
Comment
MeSH terms
Animals
Antibodies / therapeutic use*
CD47 Antigen / immunology*
CD47 Antigen / physiology*
Humans
Lymphoma, Non-Hodgkin / pathology*
Lymphoma, Non-Hodgkin / therapy*
Substances
Antibodies
CD47 Antigen